Algert Global LLC Edwards Lifesciences Corp Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Algert Global LLC holds 64,125 shares of EW stock, worth $4.35 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

64,125

Previous 4,616 1289.19%

Holding current value

$4.35 Million

Previous $426,000 893.43%

% of portfolio

0.11%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $3.55 Million - $5.58 Million	59,509 Added 1289.19%	64,125 $4.23 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $107,904 - $120,716	1,280 Added 38.37%	4,616 $426,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $308,440 - $406,321	-4,252 Reduced 56.04%	3,336 $319,000
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $59,179 - $74,571	959 Added 14.47%	7,588 $579,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $793,671 - $1.07 Million	-11,456 Reduced 63.35%	6,629 $459,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $391,350 - $445,367	5,270 Added 41.12%	18,085 $1.5 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $555,757 - $711,499	8,137 Added 173.94%	12,815 $956,000
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $6,507 - $8,475	79 Added 1.72%	4,678 $387,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $397,813 - $589,913	4,599 New	4,599 $437,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $615,838 - $775,173	-6,040 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $853,193 - $1.05 Million	-8,021 Reduced 57.04%	6,040 $782,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $1.45 Million - $1.73 Million	14,061 New	14,061 $1.59 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Edwards Lifesciences Corp Transaction History